Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 14, 2012; 18(6): 498-506
Published online Feb 14, 2012. doi: 10.3748/wjg.v18.i6.498
Published online Feb 14, 2012. doi: 10.3748/wjg.v18.i6.498
Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications
Catherine Frenette, Robert Gish, California Pacific Medical Center, San Francisco, CA 94115, United States
Author contributions: Frenette C and Gish R contributed equally to the writing of this manuscript.
Correspondence to: Catherine Frenette, MD, Medical Director of Liver Transplantation, Director of Liver Cancer Program, The Methodist Hospital, Houston, TX 77030, United States. ctfrenette@tmhs.org
Telephone: +1-713-4410179 Fax: +1-731-4415248
Received: February 21, 2011
Revised: June 6, 2011
Accepted: June 13, 2011
Published online: February 14, 2012
Revised: June 6, 2011
Accepted: June 13, 2011
Published online: February 14, 2012
Core Tip